Alternative pathways of thromboplastin-dependent activation of human factor X in plasma.
To determine the interrelationships of the major coagulation pathways, the activation of 3H-labeled factor X in normal and various deficient human plasmas was evaluated when clotting was triggered by dilute rabbit or human thromboplastin. Various dilutions of thromboplastin and calcium were added to plasma samples containing 3H-factor X, and the time course of factor X activation was determined. At a 1/250 dilution of rabbit brain thromboplastin, the rate of factor X activation in plasmas deficient in factor VIII or factor IX was 10% of the activation rate of normal plasma or of factor XI deficient plasma. Reconstitution of the deficient plasmas with factors VIII or IX, respectively, reconstituted normal factor X activation. Similar results were obtained when various dilutions of human thromboplastin replaced the rabbit thromboplastin. From these plasma experiments, it is inferred that the dilute thromboplastin-dependent activation of factor X requires factors VII, IX, and VIII. An alternative extrinsic pathway that involves factors IX and VIII may be the physiologic extrinsic pathway and hence help to explain the consistent clinical observations of bleeding diatheses in patients deficient in factors IX or VIII.
D000818:Animals; D001777:Blood Coagulation; D005170:Factor X / Q000302:isolation & purification / Q000494:pharmacology*; D006801:Humans; D011817:Rabbits; D012910:Snake Venoms / Q000494:pharmacology; D013925:Thromboplastin / Q000378:metabolism*; D014316:Tritium
D012910:Snake Venoms; D014316:Tritium; D005170:Factor X; D013925:Thromboplastin